Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Cannabis Science Inc (CBIS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0334 +7.78%
on 05/10/19
0.0375 -4.00%
on 05/17/19
+0.0003 (+0.84%)
since 04/17/19
3-Month
0.0334 +7.78%
on 05/10/19
0.0500 -28.00%
on 02/19/19
-0.0120 (-25.00%)
since 02/15/19
52-Week
0.0310 +16.13%
on 12/11/18
0.0710 -49.30%
on 06/12/18
-0.0226 (-38.57%)
since 05/17/18

Most Recent Stories

More News
Cannabis Science Releases Clinical Drug-Development Pipeline as it Transitions Into Clinical Trials; Right on Time for the Upcoming Global Health Catalyst Summit at Harvard Medical School, May 24-26, 2019

via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, hits inflection point that translates into an unprecedented progression...

CBIS : 0.0360 (-2.70%)
Independent Valuation of U.S. Patent Number 9,763,991 for Cannabinol (CBN) Initiated as Cannabis Science Negotiates Licensing and Marketing Deals in Canada and the USA to Develop and Sell CBN Products Utilizing the Company's Patent

EQNX::TICKER_START (Other OTC:CBIS), EQNX::TICKER_END

CBIS : 0.0360 (-2.70%)
Elpasso Farms Just Announced South African Health Products Regulatory Authority (SAHPRA) Awarded Elpasso Farms One of the First Medical Cannabis Cultivation Licenses; Cannabis Science Applauds

via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that the Company's strategic partner in South...

CBIS : 0.0360 (-2.70%)
Hemp CBD Uses Proving to be Endless Opportunities for Cannabis Stocks

A recent article in CannabizDaily, an industry newsletter, focused on the reasons hemp biomass, although not a 'sexy' label... can be the source of significant revenues in the ever-expanding industry....

ACB : 8.68 (-2.36%)
ACB.TO : 11.71 (-2.01%)
ACBFF : 8.6900 (-12.80%)
HEXO : 6.88 (-3.78%)
CBIS : 0.0360 (-2.70%)
POTND : 0.0200 (+32.45%)
MCOA : 0.0142 (unch)
POTN : 0.1146 (-1.21%)
HEXO.TO : 9.25 (-3.85%)
Cannabis Science Expands Into Canadian Market With Wholly-Owned Subsidiary Cannabis Science Canada Inc., Commences Negotiations for Canadian Land, Licenses, and Expansion Capital

via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the Company has expanded into the Canadian...

CBIS : 0.0360 (-2.70%)
Cannabis Science iCannabinoid Ambassadors Program Appointments Underway; Ambassadors Will Promote Company Initiatives Globally and Help Share Accurate and Reliable Health Information

via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces that today it has launched the selection and appointment...

CBIS : 0.0360 (-2.70%)
IIROC Trade Resumption - CBIS

VANCOUVER , Feb. 26, 2019 /CNW/ - Trading resumes in:

CBIS : 0.0360 (-2.70%)
IIROC Trading Halt - CBIS

VANCOUVER , Feb. 26, 2019 /CNW/ - The following issues have been halted by IIROC:

CBIS : 0.0360 (-2.70%)
Cannabis Science Set to Integrate Its Sponsored Research In Nigeria to Include Its U.S. Patent Number 9,763,991 for Compositions of Cannabinol (CBN) for Treatment of Various Neurological Conditions

EQNX::TICKER_START (Other OTC:CBIS), EQNX::TICKER_END

CBIS : 0.0360 (-2.70%)
Cannabis Science Receives Tremendous Response for CEO's Personal Shareholder Loyalty Gift; Planning Underway for the Company's 2019 Black-Tie Dinner Awards Gala Presentations

via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces that it has received an incredible response from shareholders...

CBIS : 0.0360 (-2.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade CBIS with:

Key Turning Points

2nd Resistance Point 0.0385
1st Resistance Point 0.0372
Last Price 0.0360
1st Support Level 0.0350
2nd Support Level 0.0341

See More

52-Week High 0.0710
Fibonacci 61.8% 0.0557
Fibonacci 50% 0.0510
Fibonacci 38.2% 0.0463
Last Price 0.0360
52-Week Low 0.0310

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar